-

Biocom California Statement on Silicon Valley Bank

SAN FRANCISCO & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom California, the association representing the life science industry of California, issued the following statement regarding the collapse of Silicon Valley Bank. The statement can be attributed to Joe Panetta, Biocom California’s president and CEO:

“The collapse of Silicon Valley Bank (SVB) and upheaval in the banking sector has created difficulties for many in the life science industry in California and beyond. We know that some of our 1,700 members have been impacted by this sudden and unexpected development. California companies develop groundbreaking new medicines and our ecosystem is not only extremely important to our state and the nation, but also to patients with medical needs around the world. The recent actions by the Federal Reserve, the FDIC, and Treasury to allow SVB depositors to have access to all their money is a very positive development to mitigate the potential harm to California companies that are innovating across the bioeconomy.

We will continue to monitor the situation and encourage our members to reach out to us.”

About Biocom California

Biocom California is the leader and advocate for California’s life science sector. We work on behalf of more than 1,700 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs and create robust value-driven purchasing programs.

Founded in 1995 in San Diego, Biocom California provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom California operates core offices in Los Angeles and the San Francisco Bay Area, with satellite offices in Sacramento, Washington, D.C. and Tokyo. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.

For more information on Biocom California, please visit our website at www.biocom.org. Connect with us on LinkedIn, Facebook, and Twitter (@BIOCOMCA).

Contacts

Biocom California Media Contact:
Carolyn Hawley
Evoke Canale
(619) 849-5382
Carolyn.hawley@evokegroup.com

Biocom California


Release Versions

Contacts

Biocom California Media Contact:
Carolyn Hawley
Evoke Canale
(619) 849-5382
Carolyn.hawley@evokegroup.com

Social Media Profiles
More News From Biocom California

Section 232 Pharmaceutical Tariffs - Biocom Statement

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom, the largest life science membership association, representing companies across California and major life science markets, issued the following statement in response to the recent tariffs on patented pharmaceuticals and their ingredients under Section 232 of the Trade Expansion Act. This statement may be attributed to Tim Scott, president and CEO of Biocom: Biocom shares the Administration’s interest in protecting ou...

Biocom Appoints New Members to Its Board of Directors

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom, the largest life science membership association, representing companies across California and major life science markets, today announced the appointment of Aaron K. Cohen, vice president, government affairs and public policy at Neurocrine Biosciences and Bradley Wolff, senior managing director at Evercore, to its board of directors. “Mr. Cohen and Mr. Wolff are valuable additions to our board of directors, which co...

Biocom and Octane Announce Strategic Partnership to Accelerate Innovation Across California’s Life Science and Medtech Ecosystems

SAN DIEGO & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Biocom, the largest life science membership association, representing companies across California and major life science markets, and Octane, a leading accelerator and innovation platform for technology and medtech companies, today announced a strategic partnership to expand access to capital, accelerator programs and industry networks for life science and medtech companies across California and key life science ecosystems. Through this partne...
Back to Newsroom